Table 2.
Effects of ginsenoside Rg1 (G-Rg1) and G-Rg2 on the escape latency of Alzheimer's disease (AD) mice In the Morris water maze test
| Group (n = 10) | Training day |
||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| Control | 59.9 ± 0.7 | 34.0 ± 6.1∗∗ | 21.3 ± 2.1∗∗ | 18.6 ± 3.3∗∗ | 18.9 ± 2.7∗∗ |
| AD model | 58.1 ± 2.8 | 59.9 ± 0.9 | 48.5 ± 5.6 | 50.4 ± 4.1 | 41.3 ± 6.3 |
| G-Rg1 | 59.9 ± 1.1 | 52.3 ± 6.0 | 39.2 ± 6.1 | 32.1 ± 5.0∗∗ | 27.1 ± 4.9∗∗ |
| G-Rg2 | 59.9 ± 1.2 | 42.2 ± 5.7 | 34.1 ± 5.2 | 30.6 ± 4.9∗∗ | 25.3 ± 3.7∗ |
* p < 0.05 versus AD model group (one-way analysis of variance).
** p < 0.01 versus AD model group (one-way analysis of variance).
AD, Alzheimer's disease; G-Rg1, Ginsenside Rg1; G-Rg2, Ginsenside Rg2.